207 related articles for article (PubMed ID: 28205314)
1. Comparison of LC-MS/MS vs chemiluminescent microparticle immunoassay in measuring the valproic acid concentration in plasma of epilepsy patients in a new perspective.
Wang Z; Yun Y; Xie X; You C; Miao H; Zhang F; Gao S; Chen W
J Clin Lab Anal; 2018 Jan; 32(1):. PubMed ID: 28205314
[TBL] [Abstract][Full Text] [Related]
2. Simultaneous Determination of Valproic Acid and Its Major Metabolites by UHPLC-MS/MS in Chinese Patients: Application to Therapeutic Drug Monitoring.
Zhao M; Zhang T; Li G; Qiu F; Sun Y; Zhao L
J Chromatogr Sci; 2017 Apr; 55(4):436-444. PubMed ID: 27993840
[TBL] [Abstract][Full Text] [Related]
3. Development and Validation of a Simple and Rapid UPLC-MS Assay for Valproic Acid and Its Comparison With Immunoassay and HPLC Methods.
Zhao M; Li G; Qiu F; Sun Y; Xu Y; Zhao L
Ther Drug Monit; 2016 Apr; 38(2):246-52. PubMed ID: 26488205
[TBL] [Abstract][Full Text] [Related]
4. A rapid and simple HPLC-MS/MS method for the simultaneous quantification of valproic acid and its five metabolites in human plasma and application to study pharmacokinetic interaction in Chinese epilepsy patients.
Wen D; Chen Z; Yang C; Liu H; Li H; Chen J; Dai Q; Zhong G; Qin J; Ni G; Huang M; Zhou L; Wang X
J Pharm Biomed Anal; 2018 Feb; 149():448-456. PubMed ID: 29169113
[TBL] [Abstract][Full Text] [Related]
5. Multi-site analytical evaluation of a chemiluminescent magnetic microparticle immunoassay (CMIA) for sirolimus on the Abbott ARCHITECT analyzer.
Schmid RW; Lotz J; Schweigert R; Lackner K; Aimo G; Friese J; Rosiere T; Dickson D; Kenney D; Maine GT
Clin Biochem; 2009 Oct; 42(15):1543-8. PubMed ID: 19563794
[TBL] [Abstract][Full Text] [Related]
6. Effect of Carbamazepine 10, 11-Epoxide on Serum Carbamazepine Measurement Using a New CMIA Assay: Comparison of Values Obtained by Using PETINIA, CEDIA and Liquid Chromatography Combined with Tandem Mass Spectrometry.
Dasgupta A; Davis B; Slawson MH; Johnson-Davis KL
Ann Clin Lab Sci; 2016 May; 46(3):242-6. PubMed ID: 27312546
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of a Methotrexate Chemiluminescent Microparticle Immunoassay: Comparison to Fluorescence Polarization Immunoassay and Liquid Chromatography-Tandem Mass Spectrometry.
Bouquié R; Grégoire M; Hernando H; Azoulay C; Dailly E; Monteil-Ganière C; Pineau A; Deslandes G; Jolliet P
Am J Clin Pathol; 2016 Jul; 146(1):119-24. PubMed ID: 27357291
[TBL] [Abstract][Full Text] [Related]
8. Successful LC-MS/MS assay development and validation for determination of valproic acid and its metabolites supporting proactive pharmacovigilance.
Wang WJ; Zhao YT; Dai HR; Zhang YY; Wang J; Guo HL; Ding XS; Chen F
J Pharm Biomed Anal; 2023 Sep; 234():115538. PubMed ID: 37354631
[TBL] [Abstract][Full Text] [Related]
9. Simultaneous determination of valproic acid and 2-propyl-4-pentenoic acid for the prediction of clinical adverse effects in Chinese patients with epilepsy.
Chen ZJ; Wang XD; Wang HS; Chen SD; Zhou LM; Li JL; Shu WY; Zhou JQ; Fang ZY; Zhang Y; Huang M
Seizure; 2012 Mar; 21(2):110-7. PubMed ID: 22055352
[TBL] [Abstract][Full Text] [Related]
10. Simple and accurate quantitative analysis of ten antiepileptic drugs in human plasma by liquid chromatography/tandem mass spectrometry.
Kim KB; Seo KA; Kim SE; Bae SK; Kim DH; Shin JG
J Pharm Biomed Anal; 2011 Dec; 56(4):771-7. PubMed ID: 21840666
[TBL] [Abstract][Full Text] [Related]
11. Improved accuracy of an tandem liquid chromatography-mass spectrometry method measuring 24R,25-dihydroxyvitamin D
Dowling KG; Hull G; Sundvall J; Lamberg-Allardt C; Cashman KD
J Chromatogr A; 2017 May; 1497():102-109. PubMed ID: 28372841
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of valproate effects on acylcarnitine in epileptic children by LC-MS/MS.
Nakajima Y; Ito T; Maeda Y; Ichiki S; Kobayashi S; Ando N; Hussein MH; Kurono Y; Sugiyama N; Togari H
Brain Dev; 2011 Nov; 33(10):816-23. PubMed ID: 21196091
[TBL] [Abstract][Full Text] [Related]
13. LC-MS/MS method for simultaneous determination of valproic acid and major metabolites in human plasma.
Gao S; Miao H; Tao X; Jiang B; Xiao Y; Cai F; Yun Y; Li J; Chen W
J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Jul; 879(21):1939-44. PubMed ID: 21664885
[TBL] [Abstract][Full Text] [Related]
14. Association of Valproic Acid and Its Main Metabolites' Plasma Concentrations with Clinical Outcomes among Epilepsy Patients: A 10-Year Retrospective Study Based on Therapeutic Drug Monitoring.
Li RT; Chen ZY; Tang SY; Wen DS; Ren RN; Zhang XX; Liu SZ; Zhou S; Wang XD; Zhou LM; Huang M
Drug Metab Dispos; 2024 Feb; 52(3):210-217. PubMed ID: 38195521
[TBL] [Abstract][Full Text] [Related]
15. A new derivatization method to enhance sensitivity for the determination of low levels of valproic acid in human plasma.
Zhang JF; Zhang ZQ; Dong WC; Jiang Y
J Chromatogr Sci; 2014; 52(10):1173-80. PubMed ID: 24243686
[TBL] [Abstract][Full Text] [Related]
16. Factors Influencing Sodium Valproate Serum Concentrations in Patients with Epilepsy Based on Logistic Regression Analysis.
Lan X; Mo K; Nong L; He Y; Sun Y
Med Sci Monit; 2021 Nov; 27():e934275. PubMed ID: 34776507
[TBL] [Abstract][Full Text] [Related]
17. Immunosuppressive drugs in whole blood: validation of a commercially available liquid chromatography/tandem mass spectrometry kit and comparison with immunochemical assays.
Polledri E; Mercadante R; Ferraris Fusarini C; Maiavacca R; Fustinoni S
Rapid Commun Mass Spectrom; 2017 Jul; 31(13):1111-1120. PubMed ID: 28439923
[TBL] [Abstract][Full Text] [Related]
18. A LC-MS/MS method for therapeutic drug monitoring of carbamazepine, lamotrigine and valproic acid in DBS.
Linder C; Andersson M; Wide K; Beck O; Pohanka A
Bioanalysis; 2015; 7(16):2031-9. PubMed ID: 26327183
[TBL] [Abstract][Full Text] [Related]
19. Urinary metabolites of valproic acid in epileptic patients.
Katayama H; Watanabe M; Yoshitomi H; Yoshida H; Kimoto H; Kamiya A; Hayashi T; Akimura T
Biol Pharm Bull; 1998 Mar; 21(3):304-7. PubMed ID: 9556166
[TBL] [Abstract][Full Text] [Related]
20. Associations of CYP2C9 and CYP2A6 Polymorphisms with the Concentrations of Valproate and its Hepatotoxin Metabolites and Valproate-Induced Hepatotoxicity.
Zhao M; Zhang T; Li G; Qiu F; Sun Y; Zhao L
Basic Clin Pharmacol Toxicol; 2017 Aug; 121(2):138-143. PubMed ID: 28273397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
